Durfee Sara M., Selland Donna-Lee G., Smith Darrell N., Lester Susan C., Kaelin Carolyn M., Meyer Jack E.
Departments of Radiology, Pathology, and Surgery, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts.
Breast J. 2000 Jul;6(4):247-251. doi: 10.1046/j.1524-4741.2000.99111.x.
The purpose of this study was to determine the utility of sonography in the evaluation of palpable breast cancers invisible on mammography. A retrospective review of the pathology department's database was used to identify patients with palpable breast cancers. Consecutive patients that had excision between January 1992 and September 1997 were included. Mammograms and breast ultrasounds were reviewed retrospectively and correlated with pathologic and surgical findings. During the study period 298 women presented with a palpable breast cancer for imaging at our institution. Of these, 38 cancers (12.8%) were not seen on mammography. In 32 patients where no mammographic abnormality was found, ultrasound was able to detect a mass corresponding to the area of clinical concern. Histologic tumor types included 30 invasive ductal carcinomas, 5 ductal carcinomas in situ, and 3 invasive lobular carcinomas. Mammographic density was mild with scattered fibroglandular densities in 2 (5%), heterogeneously dense in 12 (32%), and extremely dense in 24 (63%). Thirty-one masses (97%) were hypoechoic and 1 (3%) was echogenic. Lesion margins were irregular in 23 (72%), lobulated in 5 (16%), and well-circumscribed in 4 (12%). In this group of patients the combination of mammography and ultrasound of the mass demonstrated 99% of the palpable cancers. In patients presenting with a breast mass on physical examination in whom mammography fails to demonstrate an abnormality, supplemental ultrasound is helpful in most instances to further characterize the lesion.
本研究的目的是确定超声检查在评估乳腺钼靶检查未显示的可触及乳腺癌中的作用。通过回顾病理科数据库来识别患有可触及乳腺癌的患者。纳入了1992年1月至1997年9月期间连续接受手术切除的患者。对乳腺钼靶片和乳腺超声检查进行回顾性分析,并与病理和手术结果进行对照。在研究期间,298名女性因可触及乳腺癌在本机构进行影像学检查。其中,38例癌症(12.8%)在乳腺钼靶检查中未被发现。在32例乳腺钼靶检查未发现异常的患者中,超声能够检测到与临床关注区域相对应的肿块。组织学肿瘤类型包括30例浸润性导管癌、5例导管原位癌和3例浸润性小叶癌。乳腺钼靶密度轻度,散在纤维腺体密度2例(5%),不均匀致密12例(32%),极度致密24例(63%)。31个肿块(97%)为低回声,1个(3%)为高回声。病变边缘不规则23例(72%),分叶状5例(16%),边界清晰4例(12%)。在这组患者中,乳腺钼靶检查和肿块超声检查相结合可显示99%的可触及癌症。对于体格检查发现乳腺肿块而乳腺钼靶检查未显示异常的患者,在大多数情况下,补充超声检查有助于进一步明确病变特征。